BusinessWire ABIONYX Pharma Announces Its Financial Agenda for the Year 2023 Business Wire News Jan 13, 2023 TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for…